With a type 2 diabetes epidemic growing in the Unites States—it’s estimated that more than 3.7 million African Americans suffer from the disease—pharmaceutical companies are creating more drugs to deal with the problem. But the Food and Drug Administration (FDA) has set new standards for these recent drugs—they will be screened closely for heart health dangers.

Over the years, the medical community, especially doctors who treat diabetes, voiced concerns about a number of diabetes drugs that lowered blood sugar levels, but also increased the risk for heart attacks and other heart-related illnesses. Under the new FDA policy, drug companies will have to test drugs on greater numbers of high-risk patients—the elderly, those with advanced diabetes and those with kidney problems—as opposed to using younger and healthier patients who tend to have few heart health issues.